Thursday, February 22, 2018
Create an account
In the Know
National Meeting Summaries
ESP Tool Kit III
ESP Patient Referral Tool
UDT Interactive Cases
Patient Education Series
Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms
Therapeutic Advances and Evolving Treatment Strategies: Novel Approaches to Migraine Management
Case Studies in Migraine
Targeting CGRP: Emerging Solutions in Migraine
Recognizing and Treating Breakthrough Pain: Aligning Our Treatment Approach
Targeting Breakthrough Pain: A Patient Case Report
Managing Breakthrough Pain Across the Provider Continuum
Clinical Dialogues in Pain - OIC
The Emerging Solutions in Pain Responsible Opioid Prescribing Series
Clinical Dialogues in Pain
Effective Strategies in Managing Breakthrough Pain
National Meeting Highlights
Virtual Grand Rounds
How to Talk to Your Patients About Opioid-induced Constipation: A Dialogue About New Advances
Navigating Pitfalls in OIC: A Patient-focused Strategy
Patient-Centered Approaches to Treatment of Migraine: Real-World Cases with Real-World Challenges
Knowledge Library - Practice
What are some key counseling points pharmacists should make when talking to patients about opioids?
Kathryn L. Hahn, PharmD, DAAPM, CPE
March 30, 2012
Dr. Hahn discusses what key counseling points a community pharmacist can utilize to allay the fears of potential addiction to their pain patient using chronic opioid therapy.
What is pseudoaddiction?
Bruce D. Nicholson, MD
March 16, 2012
Dr. Nicholson discusses if the undertreatment of pain can result in pseudoaddiction and defines pseudoaddiction.
What key factors should be included in a treatment agreement?
Kenneth L. Kirsh, PhD
February 24, 2012
Dr. Kirsh discusses what key factors should be included in a treatment agreement.
How can I improve communication with a chronic pain patient during a brief follow-up visit?
Daniel B. Carr, MD, FABPM
November 4, 2011
How can we best assess the contributions that community-based pharmacists make to patient outcomes?
Scott Strassels, PharmD, PhD, BCPS
July 29, 2011
Dr. Strassels discusses how we can best assess the contributions that community-based pharmacists make to patient outcomes and if there is data to support this.
Page 3 of 3
Results 21 - 25 of 25
Worldwide, Inc. Links